INFECTIOUS COMPLICATIONS OCCURRING IN LIVER TRANSPLANT RECIPIENTS RECEIVING MYCOPHENOLATE MOFETIL

1998 ◽  
Vol 66 (5) ◽  
pp. 593-598 ◽  
Author(s):  
David L. Paterson ◽  
Nina Singh ◽  
Annunziata Panebianco ◽  
Cheryl F. Wannstedt ◽  
Marilyn M. Wagener ◽  
...  
Keyword(s):  
Mycophenolate Mofetil ◽  
Liver Transplant ◽  
Infectious Complications ◽  
Transplant Recipients ◽  
Liver Transplant Recipients

Mycophenolate mofetil rescue therapy in liver transplant recipients

1997 ◽  
Vol 29 (1-2) ◽  
pp. 549-552 ◽  
Author(s):  
A. Gavlik ◽  
M.G. Goldberg ◽  
A. Tsaroucha ◽  
M.G. Webb ◽  
R.T. Khan ◽  
...  
Keyword(s):  
Mycophenolate Mofetil ◽  
Liver Transplant ◽  
Rescue Therapy ◽  
Transplant Recipients ◽  
Liver Transplant Recipients

Biliary and urinary neopterin concentrations in monitoring liver-allograft recipients

1993 ◽  
Vol 39 (1) ◽  
pp. 45-47 ◽  
Author(s):  
A Hausen ◽  
C Aichberger ◽  
A Königsrainer ◽  
G Weiss ◽  
R Margreiter ◽  
...  
Keyword(s):  
Liver Transplant ◽  
Cytomegalovirus Infection ◽  
Infectious Complications ◽  
Transplant Recipients ◽  
Liver Allograft ◽  
Post Transplant ◽  
Bile Fluid ◽  
Urinary Neopterin ◽  
Liver Transplant Recipients

Abstract Biliary neopterin concentrations were measured daily in nine liver-transplant recipients during the early post-transplant period (on average, 25 days). Concentrations increased strongly during rejection episodes and decreased quickly after successful antirejection therapy. Contrary to the changes of urinary neopterin, cytomegalovirus infection and hepatitis were not associated with an increase in biliary neopterin concentrations. Therefore, measurement of neopterin in bile fluid and in urine may aid in distinguishing rejection from infectious complications in liver-allograft recipients.

Sign in / Sign up

Export Citation Format

Share Document